Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores

Minerva Medica

Volumn 103, Issue 5, 2012, Pages 369-376

  Senates E ^a,b   Colak Y ^c   Yesil A ^a   Coskunpinar E ^d   Sahin O ^e   Kahraman, O T ^d   Erkalma Senates B ^f   Tuncer, I ^c  

^a HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c GOZTEPE TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d ISTANBUL UNIVERSITY   (Turkey)

^e ISTANBUL UNIVERSITY   (Turkey)

^f Diyarbakir Education and Research Hospital   (Turkey)

Author keywords

Insulin resistance; Non alcoholic fatty liver disease; Resistin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; RESISTIN;

ADULT; ARTICLE; BIOCHEMISTRY; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FEMALE; GROUPS BY AGE; HEPATITIS; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; LIVER; MALE; PHLEBITIS; PORTAL SYSTEM; RESISTIN; VASCULITIS;

EID: 84871744951     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Erickson SK. Nonalcoholic fatty liver disease. J Lipid Res 2009;50:S412-416.
2. Sass DA, Chang P, Chopra KB. Nonalcoholic fatty liver disease: A clinical review. Dig Dis Sci 2005;50:171-80. (Pubitemid 40379159)
3. Brunt EM. Non-alcoholic steatohepatitis. Semin Liver Dis 2004;24:3-20.
4. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997;126:137-45. (Pubitemid 27058588)
5. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A et al. The natural history of non-alcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129:113-21. (Pubitemid 41002048)
6. Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G et al. Longterm follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865-73. (Pubitemid 46489550)
7. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-57. (Pubitemid 37466971)
8. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000;32:477-81.
9. Guha IN, Chattopadhyay D, Cross R, Harris S et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European liver fibrosis panel and exploring simple markers. Hepatology 2009;47:455-60. (Pubitemid 351280713)
10. Baranova A, Younossi ZM. future is around the corner: noninvasive diagnosis of the progressive nonalcoholic steatohepatitis. Hepatology 2008;47:373-5. (Pubitemid 351280704)
11. Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 2001;98:502-6. (Pubitemid 32105071)
12. Bertolani C, Sancho-Bru P, Failli P, Bataller R, Aleffi S, DeFranco R et al. Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am J Pathol 2006;169:2042-53. (Pubitemid 351181964)
13. Wong VW, Hui AY, Tsang SW, Chan JL, Tse AM, Chan KF et al. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2006;4:1154-61. (Pubitemid 44311653)
14. Tsochatzis E, Papatheodoridis GV, Hadziyannis E, Georgiou A, Kafiri G, Tiniakos DG et al. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. Scand J Gastroenterol 2008;43:1128-36.
15. Pagano C, Soardo G, Esposito W, Fallo F, Basan L, Donnini D et al. Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur J Endocrinol 2005;152:113-8. (Pubitemid 40185459)
16. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association Consensus statement on inpatient diabetes and glycemic control. Diabetes Care 2006;29:1955-62.
17. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; National Heart, Lung, and Blood Institute; American Heart Association. American Heart Association;National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-8. (Pubitemid 38133916)
18. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW et al. Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-21. (Pubitemid 40770284)
19. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001;21:17-26. (Pubitemid 32240483)
20. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003;37:1202-19. (Pubitemid 36538699)
21. McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990;99:1396-400. (Pubitemid 20381876)
22. Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsy. Can J Gastroenterol 2000;14:543-8. (Pubitemid 30447225)
23. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998;114:842-5.
24. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307-12. (Pubitemid 32151228)
25. Muse ED, Obici S, Bhanot S, Monia BP, McKay RA, Rajala MW et al. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 2004;114:232-9. (Pubitemid 39071628)
26. Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 2004;126:586-97. (Pubitemid 38182315)
27. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003;362:2095-100. (Pubitemid 38035201)
28. Marra F, Aleffi S, Bertolani C, Petrai I, Vizzutti F. Review article: the pathogenesis of fibrosis in nonalcoholic steatohepatitis. Aliment Pharmacol Ther 2005;22(Suppl 2):44-7. (Pubitemid 41564382)
29. Friedman SL: Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247-50.
30. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-18. (Pubitemid 40385459)
31. Marra F, Valente AJ, Pinzani M, Abboud HE. Cultured human liverfat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J Clin Invest 1993;92:1674-80. (Pubitemid 23304529)
32. Pagano C, Soardo G, Pilon C, Milocco C, Basan L, Milan G et al. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J Clin Endocrinol Metab 2006;91:1081-6. (Pubitemid 43357784)
33. Yagmur E, Trautwein C, Gressner AM, Tacke F. Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases. Am J Gastroenterol 2006;101:1244-52. (Pubitemid 43829990)
34. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD et al. Resistin promotes endothelial cell activation - further evidence of adipokine-endothelial interaction. Circulation 2003;108:736-40. (Pubitemid 36999260)
35. Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 2004;314:415-9. (Pubitemid 38084733)
36. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005;174:5789-95. (Pubitemid 40593223)